We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+7.34%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$22.1B
AUM Growth
+$837M
Cap. Flow
-$891M
Cap. Flow %
-4.02%
Top 10 Hldgs %
11.85%
Holding
1,375
New
137
Increased
485
Reduced
440
Closed
118

Top Buys

Rank Stock Value
1
FTI icon
TechnipFMC
FTI
+$248M
2
QCOM icon
Qualcomm
QCOM
+$77.7M
3
PEP icon
PepsiCo
PEP
+$50.8M
4
ECL icon
Ecolab
ECL
+$47.9M
5
BAX icon
Baxter International
BAX
+$46.3M

Top Sells

Rank Stock Value
1
CMI icon
Cummins
CMI
+$66M
2
UBS icon
UBS Group
UBS
+$65.7M
3
AZO icon
AutoZone
AZO
+$61.6M
4
HPQ icon
HP
HPQ
+$60.5M
5
ORCL icon
Oracle
ORCL
+$60.2M

Sector Composition

Rank Sector Weight
1 Technology 16.87%
2 Healthcare 16.62%
3 Financials 12.27%
4 Consumer Discretionary 9.64%
5 Industrials 8.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSCI icon
601
MSCI
MSCI
$39.6B
$4.21M 0.02%
43,335
-8,115
-16% -$735K
TCOM icon
602
Trip.com Group
TCOM
$24.7B
$4.19M 0.02%
85,300
+3,372
+4% +$155K
PRGS icon
603
Progress Software
PRGS
$1.79B
$4.17M 0.02%
143,700
+14,400
+11% +$418K
BNDX icon
604
Vanguard Total International Bond ETF
BNDX
$82.3B
$4.12M 0.02%
76,180
+2,430
+3% +$131K
PNR icon
605
Pentair
PNR
$9.03B
$4.11M 0.02%
97,579
-1,425,602
-94% -$57M
MKTX icon
606
MarketAxess Holdings
MKTX
$5.75B
$4.11M 0.02%
21,900
+700
+3% +$127K
FOMX
607
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$4.09M 0.02%
826,437
+133,602
+19% +$1.29M
NBIX icon
608
Neurocrine Biosciences
NBIX
$15.2B
$4.08M 0.02%
+94,338
New +$4.04M
AGU
609
DELISTED
Agrium
AGU
$4.08M 0.02%
42,700
+3,039
+8% +$306K
EDU icon
610
New Oriental
EDU
$8.95B
$4.06M 0.02%
67,246
CENT icon
611
Central Garden & Pet Co
CENT
$2.51B
$4M 0.02%
134,763
-28,500
-17% -$787K
LOGI icon
612
Logitech
LOGI
$14.5B
$4M 0.02%
125,400
-3,200
-2% -$92.1K
FITB
613
Fifth Third Bancorp
FITB
$49.6B
$3.95M 0.02%
155,400
+124,800
+408% +$3.33M
SMMT icon
614
Summit Therapeutics
SMMT
$13.9B
$3.9M 0.02%
294,166
+66
+0% +$763
FLOT icon
615
iShares Floating Rate Bond ETF
FLOT
$10.8B
$3.89M 0.02%
76,510
+740
+1% +$37.6K
VOO icon
616
Vanguard S&P 500 ETF
VOO
$1.04T
$3.84M 0.02%
17,755
+6,540
+58% +$1.4M
WAB icon
617
Wabtec
WAB
$47B
$3.83M 0.02%
49,085
+41,285
+529% +$3.41M
INFY icon
618
Infosys
INFY
$45.8B
$3.83M 0.02%
484,276
+32,422
+7% +$242K
DBV
619
DELISTED
Invesco DB G10 Currency Harvest Fund
DBV
$3.82M 0.02%
151,320
+3,220
+2% +$81.8K
HAS icon
620
Hasbro
HAS
$12.7B
$3.82M 0.02%
38,284
-21,416
-36% -$1.98M
AGIO icon
621
Agios Pharmaceuticals
AGIO
$1.96B
$3.75M 0.02%
64,304
-1,947
-3% -$93.3K
NEM icon
622
Newmont
NEM
$131B
$3.75M 0.02%
113,663
-559,931
-83% -$19.6M
AMP icon
623
Ameriprise Financial
AMP
$49.4B
$3.73M 0.02%
28,774
-2,726
-9% -$337K
STML
624
DELISTED
Stemline Therapeutics, Inc.
STML
$3.71M 0.02%
+434,183
New +$3.96M
DIN icon
625
Dine Brands
DIN
$343M
$3.71M 0.02%
68,100
+37,600
+123% +$2.37M

Similar funds

Axa's Q1 2017 Portfolio in Review

As of Q1 2017, Axa held 1,375 positions worth $22.1B, up 3.9% from $21.3B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Axa withdrew a net $891M in Q1 2017, closing 118 positions and reducing 440 holdings. Its most notable exit was QIAGEN NV, an estimated $22.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Axa opened a new position in Qiagen worth $22.1M.

  • Axa's largest Q1 2017 buy was Qiagen: 720,923 shares worth $22.1M.
  • Axa added most to TechnipFMC in Q1 2017, an estimated $248M increase.
  • Axa's biggest Q1 2017 reduction was Cummins, cutting an estimated $66M.
  • Axa fully exited QIAGEN NV in Q1 2017, selling an estimated $22.3M.
  • Axa's ten largest holdings make up 12% of its $22.1B portfolio in Q1 2017.
  • Axa opened 137 new positions and closed 118 in Q1 2017.
  • Axa's portfolio value rose 3.9% quarter-over-quarter to $22.1B.

Based on Axa's 13F filing for Q1 2017, filed 11 May 2017.